Attention: World-2DPAGE is no longer maintained.
[Click to access protein entry]
Spot: 2D-000BLP (csf_human)
pI: 5.03 Mw: 86097
%vol: 0.0697402 %od: 0.0722387
================
*THRB_HUMAN*
accession n°: P00734
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BLP (csf_human)
pI: 5.03 Mw: 86097
%vol: 0.0697402 %od: 0.0722387
================
*THRB_HUMAN*
accession n°: P00734
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BS4 (csf_human)
pI: 4.62 Mw: 64469
%vol: 0.0753242 %od: 0.0426564
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BS4 (csf_human)
pI: 4.62 Mw: 64469
%vol: 0.0753242 %od: 0.0426564
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C00 (csf_human)
pI: 3.95 Mw: 47169
%vol: 0.0319479 %od: 0.0980024
================
*A1AG1_HUMAN*
accession n°: P02763
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C00 (csf_human)
pI: 3.95 Mw: 47169
%vol: 0.0319479 %od: 0.0980024
================
*A1AG1_HUMAN*
accession n°: P02763
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BPZ (csf_human)
pI: 5.90 Mw: 67939
%vol: 0.20857 %od: 0.527567
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BPZ (csf_human)
pI: 5.90 Mw: 67939
%vol: 0.20857 %od: 0.527567
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BXC (csf_human)
pI: 6.76 Mw: 54495
%vol: 0.0902591 %od: 0.0501037
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BXC (csf_human)
pI: 6.76 Mw: 54495
%vol: 0.0902591 %od: 0.0501037
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C6F (csf_human)
pI: 5.23 Mw: 33314
%vol: 0.190389 %od: 0.218554
================
*APOE_HUMAN*
accession n°: P02649
Identification Methods:
* MAPPING: {Gm} {Aa}
amino acid composition (in %): {
$m/Z=A=12.03,B=4.12,F=1.03,G=5.84,H=0.69,I=0.69,K=4.12,L=12.71,
M=2.41,P=2.75,R=11.68,S=4.81,T=3.78,V=7.56,Y=1.37,
Z=24.40; }
Spot: 2D-000C6F (csf_human)
pI: 5.23 Mw: 33314
%vol: 0.190389 %od: 0.218554
================
*APOE_HUMAN*
accession n°: P02649
Identification Methods:
* MAPPING: {Gm} {Aa}
amino acid composition (in %): {
$m/Z=A=12.03,B=4.12,F=1.03,G=5.84,H=0.69,I=0.69,K=4.12,L=12.71,
M=2.41,P=2.75,R=11.68,S=4.81,T=3.78,V=7.56,Y=1.37,
Z=24.40; }
[Click to access protein entry]
Spot: 2D-000BS5 (csf_human)
pI: 5.77 Mw: 64305
%vol: 0.206882 %od: 0.1449
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BS5 (csf_human)
pI: 5.77 Mw: 64305
%vol: 0.206882 %od: 0.1449
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BY1 (csf_human)
pI: 7.49 Mw: 52453
%vol: 0.135324 %od: 0.160745
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BY1 (csf_human)
pI: 7.49 Mw: 52453
%vol: 0.135324 %od: 0.160745
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C2B (csf_human)
pI: 3.98 Mw: 43600
%vol: 0.0190908 %od: 0.00293024
================
*A1AG1_HUMAN*
accession n°: P02763
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C2B (csf_human)
pI: 3.98 Mw: 43600
%vol: 0.0190908 %od: 0.00293024
================
*A1AG1_HUMAN*
accession n°: P02763
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BJ7 (csf_human)
pI: 5.91 Mw: 104427
%vol: 0.113246 %od: 0.105318
================
*CO3_HUMAN*
accession n°: P01024
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BJ7 (csf_human)
pI: 5.91 Mw: 104427
%vol: 0.113246 %od: 0.105318
================
*CO3_HUMAN*
accession n°: P01024
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C1N (csf_human)
pI: 5.05 Mw: 45212
%vol: 0.0640258 %od: 0.0234078
================
*APOA4_HUMAN*
accession n°: P06727
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C1N (csf_human)
pI: 5.05 Mw: 45212
%vol: 0.0640258 %od: 0.0234078
================
*APOA4_HUMAN*
accession n°: P06727
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BUA (csf_human)
pI: 4.51 Mw: 58672
%vol: 0.0945451 %od: 0.0985524
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BUA (csf_human)
pI: 4.51 Mw: 58672
%vol: 0.0945451 %od: 0.0985524
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBK (csf_human)
pI: 5.05 Mw: 23264
%vol: 0.0796101 %od: 0.0662419
================
*APOA1_HUMAN*
accession n°: P02647
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBK (csf_human)
pI: 5.05 Mw: 23264
%vol: 0.0796101 %od: 0.0662419
================
*APOA1_HUMAN*
accession n°: P02647
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA7 (csf_human)
pI: 6.20 Mw: 25814
%vol: 0.0372725 %od: 0.0161042
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA7 (csf_human)
pI: 6.20 Mw: 25814
%vol: 0.0372725 %od: 0.0161042
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BE8 (csf_human)
pI: 5.26 Mw: 149779
%vol: 0.0979216 %od: 0.0294022
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BE8 (csf_human)
pI: 5.26 Mw: 149779
%vol: 0.0979216 %od: 0.0294022
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C22 (csf_human)
pI: 4.81 Mw: 43864
%vol: 0.107662 %od: 0.0748647
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C22 (csf_human)
pI: 4.81 Mw: 43864
%vol: 0.107662 %od: 0.0748647
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BZ6 (csf_human)
pI: 5.59 Mw: 51395
%vol: 0.23844 %od: 0.327556
================
*FIBG_HUMAN*
accession n°: P02679
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BZ6 (csf_human)
pI: 5.59 Mw: 51395
%vol: 0.23844 %od: 0.327556
================
*FIBG_HUMAN*
accession n°: P02679
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C45 (csf_human)
pI: 4.82 Mw: 37892
%vol: 0.110519 %od: 0.175948
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C45 (csf_human)
pI: 4.82 Mw: 37892
%vol: 0.110519 %od: 0.175948
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BEE (csf_human)
pI: 5.28 Mw: 149779
%vol: 0.0920774 %od: 0.0302613
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BEE (csf_human)
pI: 5.28 Mw: 149779
%vol: 0.0920774 %od: 0.0302613
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BFQ (csf_human)
pI: 5.17 Mw: 138213
%vol: 0.042727 %od: 0.012361
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BFQ (csf_human)
pI: 5.17 Mw: 138213
%vol: 0.042727 %od: 0.012361
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C2P (csf_human)
pI: 5.07 Mw: 42428
%vol: 0.198181 %od: 0.216499
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C2P (csf_human)
pI: 5.07 Mw: 42428
%vol: 0.198181 %od: 0.216499
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C66 (csf_human)
pI: 5.14 Mw: 33980
%vol: 0.120649 %od: 0.061041
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C66 (csf_human)
pI: 5.14 Mw: 33980
%vol: 0.120649 %od: 0.061041
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C4T (csf_human)
pI: 4.82 Mw: 36782
%vol: 0.0996101 %od: 0.0748282
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C4T (csf_human)
pI: 4.82 Mw: 36782
%vol: 0.0996101 %od: 0.0748282
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BNC (csf_human)
pI: 5.43 Mw: 76342
%vol: 0.138311 %od: 0.314833
================
*HEMO_HUMAN*
accession n°: P02790
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BNC (csf_human)
pI: 5.43 Mw: 76342
%vol: 0.138311 %od: 0.314833
================
*HEMO_HUMAN*
accession n°: P02790
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BJL (csf_human)
pI: 6.14 Mw: 102400
%vol: 0.108181 %od: 0.063869
================
*CO3_HUMAN*
accession n°: P01024
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BJL (csf_human)
pI: 6.14 Mw: 102400
%vol: 0.108181 %od: 0.063869
================
*CO3_HUMAN*
accession n°: P01024
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9I (csf_human)
pI: 5.88 Mw: 27192
%vol: 0.0240258 %od: 0.00987374
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9I (csf_human)
pI: 5.88 Mw: 27192
%vol: 0.0240258 %od: 0.00987374
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C40 (csf_human)
pI: 4.73 Mw: 38269
%vol: 0.0797398 %od: 0.118609
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C40 (csf_human)
pI: 4.73 Mw: 38269
%vol: 0.0797398 %od: 0.118609
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C60 (csf_human)
pI: 5.67 Mw: 34233
%vol: 0.0402595 %od: 0.0346323
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C60 (csf_human)
pI: 5.67 Mw: 34233
%vol: 0.0402595 %od: 0.0346323
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BP2 (csf_human)
pI: 5.81 Mw: 66470
%vol: 0.23857 %od: 1.43384
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BP2 (csf_human)
pI: 5.81 Mw: 66470
%vol: 0.23857 %od: 1.43384
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C5U (csf_human)
pI: 5.51 Mw: 34403
%vol: 0.155584 %od: 0.202517
================
*TTHY_HUMAN*
accession n°: P02766
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C5U (csf_human)
pI: 5.51 Mw: 34403
%vol: 0.155584 %od: 0.202517
================
*TTHY_HUMAN*
accession n°: P02766
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BJQ (csf_human)
pI: 6.21 Mw: 101899
%vol: 0.116623 %od: 0.0643533
================
*CO3_HUMAN*
accession n°: P01024
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BJQ (csf_human)
pI: 6.21 Mw: 101899
%vol: 0.116623 %od: 0.0643533
================
*CO3_HUMAN*
accession n°: P01024
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAU (csf_human)
pI: 6.97 Mw: 24566
%vol: 0.0961033 %od: 0.0519971
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAU (csf_human)
pI: 6.97 Mw: 24566
%vol: 0.0961033 %od: 0.0519971
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BMP (csf_human)
pI: 6.22 Mw: 81517
%vol: 0.205194 %od: 0.292036
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BMP (csf_human)
pI: 6.22 Mw: 81517
%vol: 0.205194 %od: 0.292036
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C10 (csf_human)
pI: 4.68 Mw: 47026
%vol: 0.0462335 %od: 0.0331599
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C10 (csf_human)
pI: 4.68 Mw: 47026
%vol: 0.0462335 %od: 0.0331599
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BY5 (csf_human)
pI: 7.03 Mw: 51789
%vol: 0.181947 %od: 0.661866
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BY5 (csf_human)
pI: 7.03 Mw: 51789
%vol: 0.181947 %od: 0.661866
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BYK (csf_human)
pI: 6.45 Mw: 52319
%vol: 0.128051 %od: 0.100144
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BYK (csf_human)
pI: 6.45 Mw: 52319
%vol: 0.128051 %od: 0.100144
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BE3 (csf_human)
pI: 5.15 Mw: 152053
%vol: 0.0580519 %od: 0.0207648
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BE3 (csf_human)
pI: 5.15 Mw: 152053
%vol: 0.0580519 %od: 0.0207648
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8O (csf_human)
pI: 4.31 Mw: 29072
%vol: 0.0254544 %od: 0.0106452
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8O (csf_human)
pI: 4.31 Mw: 29072
%vol: 0.0254544 %od: 0.0106452
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C64 (csf_human)
pI: 4.95 Mw: 34064
%vol: 0.0645454 %od: 0.0556818
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C64 (csf_human)
pI: 4.95 Mw: 34064
%vol: 0.0645454 %od: 0.0556818
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C1H (csf_human)
pI: 4.80 Mw: 45624
%vol: 0.125584 %od: 0.150253
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C1H (csf_human)
pI: 4.80 Mw: 45624
%vol: 0.125584 %od: 0.150253
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C1K (csf_human)
pI: 4.69 Mw: 45486
%vol: 0.04974 %od: 0.0386431
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C1K (csf_human)
pI: 4.69 Mw: 45486
%vol: 0.04974 %od: 0.0386431
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBP (csf_human)
pI: 8.14 Mw: 23264
%vol: 0.172337 %od: 0.099825
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBP (csf_human)
pI: 8.14 Mw: 23264
%vol: 0.172337 %od: 0.099825
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BOK (csf_human)
pI: 4.40 Mw: 70976
%vol: 0.0603893 %od: 0.0753247
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BOK (csf_human)
pI: 4.40 Mw: 70976
%vol: 0.0603893 %od: 0.0753247
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BVY (csf_human)
pI: 4.50 Mw: 57051
%vol: 0.0718179 %od: 0.0183407
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BVY (csf_human)
pI: 4.50 Mw: 57051
%vol: 0.0718179 %od: 0.0183407
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BE6 (csf_human)
pI: 5.20 Mw: 150533
%vol: 0.0945451 %od: 0.0268735
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BE6 (csf_human)
pI: 5.20 Mw: 150533
%vol: 0.0945451 %od: 0.0268735
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C6I (csf_human)
pI: 5.08 Mw: 33314
%vol: 0.0538958 %od: 0.0170046
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C6I (csf_human)
pI: 5.08 Mw: 33314
%vol: 0.0538958 %od: 0.0170046
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BIE (csf_human)
pI: 6.91 Mw: 108602
%vol: 0.0512984 %od: 0.0906451
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BIE (csf_human)
pI: 6.91 Mw: 108602
%vol: 0.0512984 %od: 0.0906451
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C5W (csf_human)
pI: 5.07 Mw: 34489
%vol: 0.162726 %od: 0.144086
================
*APOE_HUMAN*
accession n°: P02649
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C5W (csf_human)
pI: 5.07 Mw: 34489
%vol: 0.162726 %od: 0.144086
================
*APOE_HUMAN*
accession n°: P02649
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BN2 (csf_human)
pI: 6.48 Mw: 78600
%vol: 0.239869 %od: 0.437732
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BN2 (csf_human)
pI: 6.48 Mw: 78600
%vol: 0.239869 %od: 0.437732
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BFO (csf_human)
pI: 5.14 Mw: 139609
%vol: 0.0449348 %od: 0.0205239
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BFO (csf_human)
pI: 5.14 Mw: 139609
%vol: 0.0449348 %od: 0.0205239
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BLK (csf_human)
pI: 4.88 Mw: 86727
%vol: 0.053766 %od: 0.0173454
================
*THRB_HUMAN*
accession n°: P00734
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BLK (csf_human)
pI: 4.88 Mw: 86727
%vol: 0.053766 %od: 0.0173454
================
*THRB_HUMAN*
accession n°: P00734
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAB (csf_human)
pI: 6.53 Mw: 25182
%vol: 0.252206 %od: 0.476047
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAB (csf_human)
pI: 6.53 Mw: 25182
%vol: 0.252206 %od: 0.476047
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BLV (csf_human)
pI: 6.28 Mw: 85472
%vol: 0.167921 %od: 0.0871503
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BLV (csf_human)
pI: 6.28 Mw: 85472
%vol: 0.167921 %od: 0.0871503
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8S (csf_human)
pI: 4.46 Mw: 28714
%vol: 0.0309089 %od: 0.0156758
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8S (csf_human)
pI: 4.46 Mw: 28714
%vol: 0.0309089 %od: 0.0156758
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C32 (csf_human)
pI: 4.83 Mw: 41665
%vol: 0.0910382 %od: 0.113393
================
*ZA2G_HUMAN*
accession n°: P25311
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C32 (csf_human)
pI: 4.83 Mw: 41665
%vol: 0.0910382 %od: 0.113393
================
*ZA2G_HUMAN*
accession n°: P25311
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9B (csf_human)
pI: 4.55 Mw: 27259
%vol: 0.026883 %od: 0.0258586
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9B (csf_human)
pI: 4.55 Mw: 27259
%vol: 0.026883 %od: 0.0258586
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8U (csf_human)
pI: 5.80 Mw: 28643
%vol: 0.0275323 %od: 0.0157658
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8U (csf_human)
pI: 5.80 Mw: 28643
%vol: 0.0275323 %od: 0.0157658
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BLU (csf_human)
pI: 5.08 Mw: 85784
%vol: 0.0441556 %od: 0.0125265
================
*THRB_HUMAN*
accession n°: P00734
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BLU (csf_human)
pI: 5.08 Mw: 85784
%vol: 0.0441556 %od: 0.0125265
================
*THRB_HUMAN*
accession n°: P00734
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C6R (csf_human)
pI: 5.66 Mw: 32099
%vol: 0.0624671 %od: 0.163996
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C6R (csf_human)
pI: 5.66 Mw: 32099
%vol: 0.0624671 %od: 0.163996
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C89 (csf_human)
pI: 5.58 Mw: 29653
%vol: 0.026883 %od: 0.0492738
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C89 (csf_human)
pI: 5.58 Mw: 29653
%vol: 0.026883 %od: 0.0492738
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAW (csf_human)
pI: 8.10 Mw: 24204
%vol: 0.152726 %od: 0.311562
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAW (csf_human)
pI: 8.10 Mw: 24204
%vol: 0.152726 %od: 0.311562
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CDF (csf_human)
pI: 5.24 Mw: 19621
%vol: 0.109869 %od: 0.076028
================
*RET4_HUMAN*
accession n°: P02753
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CDF (csf_human)
pI: 5.24 Mw: 19621
%vol: 0.109869 %od: 0.076028
================
*RET4_HUMAN*
accession n°: P02753
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C1S (csf_human)
pI: 5.23 Mw: 44803
%vol: 0.0640258 %od: 0.0249314
================
*ACTB_HUMAN*
accession n°: P60709
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C1S (csf_human)
pI: 5.23 Mw: 44803
%vol: 0.0640258 %od: 0.0249314
================
*ACTB_HUMAN*
accession n°: P60709
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9K (csf_human)
pI: 4.67 Mw: 26990
%vol: 0.031818 %od: 0.0249484
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9K (csf_human)
pI: 4.67 Mw: 26990
%vol: 0.031818 %od: 0.0249484
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BRA (csf_human)
pI: 4.58 Mw: 65462
%vol: 0.106363 %od: 0.0791676
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BRA (csf_human)
pI: 4.58 Mw: 65462
%vol: 0.106363 %od: 0.0791676
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C1L (csf_human)
pI: 4.92 Mw: 44398
%vol: 0.181428 %od: 0.34791
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C1L (csf_human)
pI: 4.92 Mw: 44398
%vol: 0.181428 %od: 0.34791
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C95 (csf_human)
pI: 4.46 Mw: 27736
%vol: 0.0307791 %od: 0.0314806
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C95 (csf_human)
pI: 4.46 Mw: 27736
%vol: 0.0307791 %od: 0.0314806
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BOF (csf_human)
pI: 5.67 Mw: 71495
%vol: 0.226752 %od: 0.419591
================
*HEMO_HUMAN*
accession n°: P02790
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BOF (csf_human)
pI: 5.67 Mw: 71495
%vol: 0.226752 %od: 0.419591
================
*HEMO_HUMAN*
accession n°: P02790
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CEC (csf_human)
pI: 5.67 Mw: 17109
%vol: 0.113246 %od: 0.0940451
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CEC (csf_human)
pI: 5.67 Mw: 17109
%vol: 0.113246 %od: 0.0940451
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C3S (csf_human)
pI: 4.65 Mw: 39035
%vol: 0.0354544 %od: 0.0262067
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C3S (csf_human)
pI: 4.65 Mw: 39035
%vol: 0.0354544 %od: 0.0262067
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BJP (csf_human)
pI: 6.07 Mw: 102400
%vol: 0.144415 %od: 0.0554677
================
*CO3_HUMAN*
accession n°: P01024
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BJP (csf_human)
pI: 6.07 Mw: 102400
%vol: 0.144415 %od: 0.0554677
================
*CO3_HUMAN*
accession n°: P01024
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBM (csf_human)
pI: 5.22 Mw: 23149
%vol: 0.240388 %od: 0.435854
================
*APOA1_HUMAN*
accession n°: P02647
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBM (csf_human)
pI: 5.22 Mw: 23149
%vol: 0.240388 %od: 0.435854
================
*APOA1_HUMAN*
accession n°: P02647
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C2M (csf_human)
pI: 5.36 Mw: 42557
%vol: 0.1687 %od: 0.131931
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C2M (csf_human)
pI: 5.36 Mw: 42557
%vol: 0.1687 %od: 0.131931
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CDE (csf_human)
pI: 5.06 Mw: 19621
%vol: 0.0357141 %od: 0.023824
================
*RET4_HUMAN*
accession n°: P02753
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CDE (csf_human)
pI: 5.06 Mw: 19621
%vol: 0.0357141 %od: 0.023824
================
*RET4_HUMAN*
accession n°: P02753
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BYD (csf_human)
pI: 6.36 Mw: 52990
%vol: 0.142727 %od: 0.0605786
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BYD (csf_human)
pI: 6.36 Mw: 52990
%vol: 0.142727 %od: 0.0605786
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BV7 (csf_human)
pI: 5.04 Mw: 56473
%vol: 0.266232 %od: 0.817405
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BV7 (csf_human)
pI: 5.04 Mw: 56473
%vol: 0.266232 %od: 0.817405
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BFK (csf_human)
pI: 5.10 Mw: 141728
%vol: 0.0398699 %od: 0.0143811
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BFK (csf_human)
pI: 5.10 Mw: 141728
%vol: 0.0398699 %od: 0.0143811
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BLM (csf_human)
pI: 6.16 Mw: 86727
%vol: 0.0483114 %od: 0.0321328
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BLM (csf_human)
pI: 6.16 Mw: 86727
%vol: 0.0483114 %od: 0.0321328
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C6E (csf_human)
pI: 5.15 Mw: 33149
%vol: 0.108311 %od: 0.109319
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C6E (csf_human)
pI: 5.15 Mw: 33149
%vol: 0.108311 %od: 0.109319
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAZ (csf_human)
pI: 8.42 Mw: 24085
%vol: 0.0758438 %od: 0.0740688
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAZ (csf_human)
pI: 8.42 Mw: 24085
%vol: 0.0758438 %od: 0.0740688
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BZ1 (csf_human)
pI: 6.31 Mw: 51789
%vol: 0.0732464 %od: 0.0402348
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BZ1 (csf_human)
pI: 6.31 Mw: 51789
%vol: 0.0732464 %od: 0.0402348
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBD (csf_human)
pI: 6.98 Mw: 23612
%vol: 0.226752 %od: 0.395977
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBD (csf_human)
pI: 6.98 Mw: 23612
%vol: 0.226752 %od: 0.395977
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C3A (csf_human)
pI: 4.92 Mw: 41039
%vol: 0.0603893 %od: 0.0554506
================
*ZA2G_HUMAN*
accession n°: P25311
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C3A (csf_human)
pI: 4.92 Mw: 41039
%vol: 0.0603893 %od: 0.0554506
================
*ZA2G_HUMAN*
accession n°: P25311
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C38 (csf_human)
pI: 5.43 Mw: 41288
%vol: 0.2487 %od: 0.29785
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C38 (csf_human)
pI: 5.43 Mw: 41288
%vol: 0.2487 %od: 0.29785
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BII (csf_human)
pI: 7.07 Mw: 109136
%vol: 0.0420777 %od: 0.0509993
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BII (csf_human)
pI: 7.07 Mw: 109136
%vol: 0.0420777 %od: 0.0509993
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBV (csf_human)
pI: 6.82 Mw: 22343
%vol: 0.141558 %od: 0.227086
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBV (csf_human)
pI: 6.82 Mw: 22343
%vol: 0.141558 %od: 0.227086
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9S (csf_human)
pI: 6.91 Mw: 26592
%vol: 0.0399998 %od: 0.0251261
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9S (csf_human)
pI: 6.91 Mw: 26592
%vol: 0.0399998 %od: 0.0251261
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BYE (csf_human)
pI: 6.41 Mw: 52186
%vol: 0.0967526 %od: 0.121235
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BYE (csf_human)
pI: 6.41 Mw: 52186
%vol: 0.0967526 %od: 0.121235
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C25 (csf_human)
pI: 5.07 Mw: 43600
%vol: 0.173765 %od: 0.157537
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C25 (csf_human)
pI: 5.07 Mw: 43600
%vol: 0.173765 %od: 0.157537
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BIG (csf_human)
pI: 7.32 Mw: 110752
%vol: 0.0372725 %od: 0.0358321
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BIG (csf_human)
pI: 7.32 Mw: 110752
%vol: 0.0372725 %od: 0.0358321
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C1J (csf_human)
pI: 4.09 Mw: 45624
%vol: 0.0150649 %od: 0.00562684
================
*A1AG1_HUMAN*
accession n°: P02763
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C1J (csf_human)
pI: 4.09 Mw: 45624
%vol: 0.0150649 %od: 0.00562684
================
*A1AG1_HUMAN*
accession n°: P02763
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BOZ (csf_human)
pI: 4.44 Mw: 70204
%vol: 0.0779215 %od: 0.0713698
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BOZ (csf_human)
pI: 4.44 Mw: 70204
%vol: 0.0779215 %od: 0.0713698
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BIJ (csf_human)
pI: 7.21 Mw: 109672
%vol: 0.042727 %od: 0.0470274
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BIJ (csf_human)
pI: 7.21 Mw: 109672
%vol: 0.042727 %od: 0.0470274
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C5O (csf_human)
pI: 5.08 Mw: 35266
%vol: 0.0794804 %od: 0.0221423
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C5O (csf_human)
pI: 5.08 Mw: 35266
%vol: 0.0794804 %od: 0.0221423
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CDK (csf_human)
pI: 5.24 Mw: 19254
%vol: 0.0542856 %od: 0.0180706
================
*RET4_HUMAN*
accession n°: P02753
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CDK (csf_human)
pI: 5.24 Mw: 19254
%vol: 0.0542856 %od: 0.0180706
================
*RET4_HUMAN*
accession n°: P02753
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8R (csf_human)
pI: 5.10 Mw: 29000
%vol: 0.0170129 %od: 0.0048529
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8R (csf_human)
pI: 5.10 Mw: 29000
%vol: 0.0170129 %od: 0.0048529
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BY0 (csf_human)
pI: 6.83 Mw: 51921
%vol: 0.162597 %od: 0.362836
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BY0 (csf_human)
pI: 6.83 Mw: 51921
%vol: 0.162597 %od: 0.362836
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BS3 (csf_human)
pI: 6.99 Mw: 64964
%vol: 0.0305193 %od: 0.00804842
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BS3 (csf_human)
pI: 6.99 Mw: 64964
%vol: 0.0305193 %od: 0.00804842
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BPH (csf_human)
pI: 4.48 Mw: 67939
%vol: 0.108701 %od: 0.270069
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BPH (csf_human)
pI: 4.48 Mw: 67939
%vol: 0.108701 %od: 0.270069
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BTG (csf_human)
pI: 4.43 Mw: 60957
%vol: 0.0510387 %od: 0.0308697
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BTG (csf_human)
pI: 4.43 Mw: 60957
%vol: 0.0510387 %od: 0.0308697
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C6J (csf_human)
pI: 5.60 Mw: 33149
%vol: 0.11987 %od: 0.0747162
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C6J (csf_human)
pI: 5.60 Mw: 33149
%vol: 0.11987 %od: 0.0747162
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CCM (csf_human)
pI: 8.14 Mw: 21464
%vol: 0.143116 %od: 0.132728
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CCM (csf_human)
pI: 8.14 Mw: 21464
%vol: 0.143116 %od: 0.132728
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBG (csf_human)
pI: 6.82 Mw: 23612
%vol: 0.127532 %od: 0.0555577
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBG (csf_human)
pI: 6.82 Mw: 23612
%vol: 0.127532 %od: 0.0555577
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BYH (csf_human)
pI: 6.90 Mw: 51657
%vol: 0.151298 %od: 0.222471
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BYH (csf_human)
pI: 6.90 Mw: 51657
%vol: 0.151298 %od: 0.222471
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BYX (csf_human)
pI: 5.45 Mw: 51657
%vol: 0.118181 %od: 0.11179
================
*FIBG_HUMAN*
accession n°: P02679
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BYX (csf_human)
pI: 5.45 Mw: 51657
%vol: 0.118181 %od: 0.11179
================
*FIBG_HUMAN*
accession n°: P02679
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BIC (csf_human)
pI: 6.59 Mw: 113499
%vol: 0.0423374 %od: 0.0182093
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BIC (csf_human)
pI: 6.59 Mw: 113499
%vol: 0.0423374 %od: 0.0182093
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CDM (csf_human)
pI: 5.07 Mw: 19208
%vol: 0.0184415 %od: 0.00655166
================
*RET4_HUMAN*
accession n°: P02753
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CDM (csf_human)
pI: 5.07 Mw: 19208
%vol: 0.0184415 %od: 0.00655166
================
*RET4_HUMAN*
accession n°: P02753
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C36 (csf_human)
pI: 5.36 Mw: 40915
%vol: 0.242077 %od: 0.57154
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C36 (csf_human)
pI: 5.36 Mw: 40915
%vol: 0.242077 %od: 0.57154
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C1U (csf_human)
pI: 4.02 Mw: 44264
%vol: 0.0225973 %od: 0.0101512
================
*A1AG1_HUMAN*
accession n°: P02763
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C1U (csf_human)
pI: 4.02 Mw: 44264
%vol: 0.0225973 %od: 0.0101512
================
*A1AG1_HUMAN*
accession n°: P02763
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BMV (csf_human)
pI: 6.35 Mw: 79175
%vol: 0.264414 %od: 1.03287
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BMV (csf_human)
pI: 6.35 Mw: 79175
%vol: 0.264414 %od: 1.03287
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9P (csf_human)
pI: 6.51 Mw: 26724
%vol: 0.0561039 %od: 0.052406
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9P (csf_human)
pI: 6.51 Mw: 26724
%vol: 0.0561039 %od: 0.052406
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C1P (csf_human)
pI: 5.15 Mw: 45075
%vol: 0.0346751 %od: 0.0136218
================
*APOA4_HUMAN*
accession n°: P06727
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C1P (csf_human)
pI: 5.15 Mw: 45075
%vol: 0.0346751 %od: 0.0136218
================
*APOA4_HUMAN*
accession n°: P06727
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBY (csf_human)
pI: 8.12 Mw: 22343
%vol: 0.192207 %od: 0.583529
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBY (csf_human)
pI: 8.12 Mw: 22343
%vol: 0.192207 %od: 0.583529
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9G (csf_human)
pI: 5.59 Mw: 27259
%vol: 0.0263635 %od: 0.0114435
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9G (csf_human)
pI: 5.59 Mw: 27259
%vol: 0.0263635 %od: 0.0114435
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CB4 (csf_human)
pI: 6.82 Mw: 24085
%vol: 0.114805 %od: 0.0592546
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CB4 (csf_human)
pI: 6.82 Mw: 24085
%vol: 0.114805 %od: 0.0592546
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C5P (csf_human)
pI: 4.86 Mw: 35092
%vol: 0.0654542 %od: 0.0513157
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C5P (csf_human)
pI: 4.86 Mw: 35092
%vol: 0.0654542 %od: 0.0513157
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BIF (csf_human)
pI: 6.77 Mw: 112392
%vol: 0.0488309 %od: 0.0323519
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BIF (csf_human)
pI: 6.77 Mw: 112392
%vol: 0.0488309 %od: 0.0323519
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9D (csf_human)
pI: 5.43 Mw: 27327
%vol: 0.0170129 %od: 0.00402786
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9D (csf_human)
pI: 5.43 Mw: 27327
%vol: 0.0170129 %od: 0.00402786
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BTP (csf_human)
pI: 4.78 Mw: 60493
%vol: 0.12935 %od: 0.0619439
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BTP (csf_human)
pI: 4.78 Mw: 60493
%vol: 0.12935 %od: 0.0619439
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA6 (csf_human)
pI: 5.52 Mw: 25814
%vol: 0.026883 %od: 0.0135608
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA6 (csf_human)
pI: 5.52 Mw: 25814
%vol: 0.026883 %od: 0.0135608
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BMZ (csf_human)
pI: 6.40 Mw: 78887
%vol: 0.264154 %od: 0.993614
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BMZ (csf_human)
pI: 6.40 Mw: 78887
%vol: 0.264154 %od: 0.993614
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BXX (csf_human)
pI: 6.27 Mw: 53260
%vol: 0.0840258 %od: 0.0524011
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BXX (csf_human)
pI: 6.27 Mw: 53260
%vol: 0.0840258 %od: 0.0524011
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C3J (csf_human)
pI: 5.52 Mw: 40112
%vol: 0.179999 %od: 0.161555
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C3J (csf_human)
pI: 5.52 Mw: 40112
%vol: 0.179999 %od: 0.161555
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9X (csf_human)
pI: 7.17 Mw: 26135
%vol: 0.026883 %od: 0.00865199
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9X (csf_human)
pI: 7.17 Mw: 26135
%vol: 0.026883 %od: 0.00865199
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9E (csf_human)
pI: 5.76 Mw: 27327
%vol: 0.0197402 %od: 0.00719904
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9E (csf_human)
pI: 5.76 Mw: 27327
%vol: 0.0197402 %od: 0.00719904
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BQ5 (csf_human)
pI: 5.60 Mw: 66713
%vol: 0.202596 %od: 0.790632
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BQ5 (csf_human)
pI: 5.60 Mw: 66713
%vol: 0.202596 %od: 0.790632
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA4 (csf_human)
pI: 6.31 Mw: 25814
%vol: 0.0646751 %od: 0.0386212
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA4 (csf_human)
pI: 6.31 Mw: 25814
%vol: 0.0646751 %od: 0.0386212
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BQ1 (csf_human)
pI: 6.00 Mw: 68686
%vol: 0.184934 %od: 0.147188
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BQ1 (csf_human)
pI: 6.00 Mw: 68686
%vol: 0.184934 %od: 0.147188
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BX5 (csf_human)
pI: 6.91 Mw: 54773
%vol: 0.0902591 %od: 0.0942179
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BX5 (csf_human)
pI: 6.91 Mw: 54773
%vol: 0.0902591 %od: 0.0942179
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BN3 (csf_human)
pI: 6.56 Mw: 78030
%vol: 0.205583 %od: 0.579951
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BN3 (csf_human)
pI: 6.56 Mw: 78030
%vol: 0.205583 %od: 0.579951
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BKB (csf_human)
pI: 4.82 Mw: 95142
%vol: 0.0698699 %od: 0.0650469
================
*C1S_HUMAN*
accession n°: P09871
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BKB (csf_human)
pI: 4.82 Mw: 95142
%vol: 0.0698699 %od: 0.0650469
================
*C1S_HUMAN*
accession n°: P09871
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BN6 (csf_human)
pI: 5.12 Mw: 79754
%vol: 0.161687 %od: 0.13117
================
*A1BG_HUMAN*
accession n°: P04217
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BN6 (csf_human)
pI: 5.12 Mw: 79754
%vol: 0.161687 %od: 0.13117
================
*A1BG_HUMAN*
accession n°: P04217
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BQZ (csf_human)
pI: 4.54 Mw: 66132
%vol: 0.125584 %od: 0.151318
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BQZ (csf_human)
pI: 4.54 Mw: 66132
%vol: 0.125584 %od: 0.151318
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C4S (csf_human)
pI: 4.75 Mw: 36782
%vol: 0.0518179 %od: 0.0227751
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C4S (csf_human)
pI: 4.75 Mw: 36782
%vol: 0.0518179 %od: 0.0227751
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C2N (csf_human)
pI: 5.46 Mw: 42428
%vol: 0.227531 %od: 0.191383
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C2N (csf_human)
pI: 5.46 Mw: 42428
%vol: 0.227531 %od: 0.191383
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAV (csf_human)
pI: 7.08 Mw: 24445
%vol: 0.112597 %od: 0.138551
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAV (csf_human)
pI: 7.08 Mw: 24445
%vol: 0.112597 %od: 0.138551
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BV6 (csf_human)
pI: 4.46 Mw: 57930
%vol: 0.0677921 %od: 0.0269392
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BV6 (csf_human)
pI: 4.46 Mw: 57930
%vol: 0.0677921 %od: 0.0269392
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BG6 (csf_human)
pI: 4.94 Mw: 132121
%vol: 0.0593506 %od: 0.0606418
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BG6 (csf_human)
pI: 4.94 Mw: 132121
%vol: 0.0593506 %od: 0.0606418
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BE7 (csf_human)
pI: 5.22 Mw: 150533
%vol: 0.102077 %od: 0.0372243
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BE7 (csf_human)
pI: 5.22 Mw: 150533
%vol: 0.102077 %od: 0.0372243
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C3K (csf_human)
pI: 5.44 Mw: 40212
%vol: 0.177402 %od: 0.113785
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C3K (csf_human)
pI: 5.44 Mw: 40212
%vol: 0.177402 %od: 0.113785
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BP1 (csf_human)
pI: 5.73 Mw: 67201
%vol: 0.226752 %od: 1.30084
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BP1 (csf_human)
pI: 5.73 Mw: 67201
%vol: 0.226752 %od: 1.30084
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA3 (csf_human)
pI: 6.26 Mw: 25686
%vol: 0.162986 %od: 0.209001
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA3 (csf_human)
pI: 6.26 Mw: 25686
%vol: 0.162986 %od: 0.209001
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C7Y (csf_human)
pI: 6.39 Mw: 30097
%vol: 0.096233 %od: 0.10359
================
*CO4B_HUMAN*
accession n°: P0C0L5
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C7Y (csf_human)
pI: 6.39 Mw: 30097
%vol: 0.096233 %od: 0.10359
================
*CO4B_HUMAN*
accession n°: P0C0L5
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BQ7 (csf_human)
pI: 6.03 Mw: 68436
%vol: 0.137921 %od: 0.0652538
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BQ7 (csf_human)
pI: 6.03 Mw: 68436
%vol: 0.137921 %od: 0.0652538
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA9 (csf_human)
pI: 6.35 Mw: 25307
%vol: 0.0935059 %od: 0.121603
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA9 (csf_human)
pI: 6.35 Mw: 25307
%vol: 0.0935059 %od: 0.121603
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C5X (csf_human)
pI: 5.60 Mw: 34233
%vol: 0.206882 %od: 0.329866
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C5X (csf_human)
pI: 5.60 Mw: 34233
%vol: 0.206882 %od: 0.329866
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C4Q (csf_human)
pI: 5.14 Mw: 36061
%vol: 0.13896 %od: 0.34581
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C4Q (csf_human)
pI: 5.14 Mw: 36061
%vol: 0.13896 %od: 0.34581
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAS (csf_human)
pI: 4.80 Mw: 24566
%vol: 0.034805 %od: 0.0191731
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAS (csf_human)
pI: 4.80 Mw: 24566
%vol: 0.034805 %od: 0.0191731
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BPJ (csf_human)
pI: 5.86 Mw: 66713
%vol: 0.218311 %od: 0.639817
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BPJ (csf_human)
pI: 5.86 Mw: 66713
%vol: 0.218311 %od: 0.639817
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BVN (csf_human)
pI: 5.08 Mw: 56043
%vol: 0.22922 %od: 0.494896
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BVN (csf_human)
pI: 5.08 Mw: 56043
%vol: 0.22922 %od: 0.494896
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAQ (csf_human)
pI: 6.67 Mw: 23322
%vol: 0.270908 %od: 2.95173
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAQ (csf_human)
pI: 6.67 Mw: 23322
%vol: 0.270908 %od: 2.95173
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BIW (csf_human)
pI: 6.68 Mw: 107017
%vol: 0.0485712 %od: 0.0220109
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BIW (csf_human)
pI: 6.68 Mw: 107017
%vol: 0.0485712 %od: 0.0220109
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BNE (csf_human)
pI: 6.68 Mw: 76621
%vol: 0.222466 %od: 0.446934
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BNE (csf_human)
pI: 6.68 Mw: 76621
%vol: 0.222466 %od: 0.446934
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BJW (csf_human)
pI: 4.67 Mw: 100412
%vol: 0.0479218 %od: 0.0350363
================
*C1S_HUMAN*
accession n°: P09871
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BJW (csf_human)
pI: 4.67 Mw: 100412
%vol: 0.0479218 %od: 0.0350363
================
*C1S_HUMAN*
accession n°: P09871
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C57 (csf_human)
pI: 4.77 Mw: 35705
%vol: 0.0558439 %od: 0.0581205
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C57 (csf_human)
pI: 4.77 Mw: 35705
%vol: 0.0558439 %od: 0.0581205
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C6Q (csf_human)
pI: 5.34 Mw: 32904
%vol: 0.114545 %od: 0.0667992
================
*APOE_HUMAN*
accession n°: P02649
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C6Q (csf_human)
pI: 5.34 Mw: 32904
%vol: 0.114545 %od: 0.0667992
================
*APOE_HUMAN*
accession n°: P02649
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8P (csf_human)
pI: 4.37 Mw: 29000
%vol: 0.0292206 %od: 0.0198789
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8P (csf_human)
pI: 4.37 Mw: 29000
%vol: 0.0292206 %od: 0.0198789
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C2E (csf_human)
pI: 4.75 Mw: 43206
%vol: 0.0744153 %od: 0.0551148
================
*ZA2G_HUMAN*
accession n°: P25311
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C2E (csf_human)
pI: 4.75 Mw: 43206
%vol: 0.0744153 %od: 0.0551148
================
*ZA2G_HUMAN*
accession n°: P25311
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BQ9 (csf_human)
pI: 6.09 Mw: 68436
%vol: 0.152077 %od: 0.0855562
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BQ9 (csf_human)
pI: 6.09 Mw: 68436
%vol: 0.152077 %od: 0.0855562
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BY7 (csf_human)
pI: 7.32 Mw: 51921
%vol: 0.152077 %od: 0.475112
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BY7 (csf_human)
pI: 7.32 Mw: 51921
%vol: 0.152077 %od: 0.475112
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C7T (csf_human)
pI: 4.92 Mw: 30928
%vol: 0.0302596 %od: 0.0180974
================
*AMBP_HUMAN*
accession n°: P02760
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C7T (csf_human)
pI: 4.92 Mw: 30928
%vol: 0.0302596 %od: 0.0180974
================
*AMBP_HUMAN*
accession n°: P02760
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BYL (csf_human)
pI: 6.61 Mw: 51657
%vol: 0.12974 %od: 0.290868
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BYL (csf_human)
pI: 6.61 Mw: 51657
%vol: 0.12974 %od: 0.290868
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BNP (csf_human)
pI: 5.51 Mw: 74964
%vol: 0.187791 %od: 0.348662
================
*HEMO_HUMAN*
accession n°: P02790
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BNP (csf_human)
pI: 5.51 Mw: 74964
%vol: 0.187791 %od: 0.348662
================
*HEMO_HUMAN*
accession n°: P02790
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BLR (csf_human)
pI: 6.21 Mw: 86412
%vol: 0.132077 %od: 0.0862473
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BLR (csf_human)
pI: 6.21 Mw: 86412
%vol: 0.132077 %od: 0.0862473
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CC0 (csf_human)
pI: 8.44 Mw: 22449
%vol: 0.097402 %od: 0.150569
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CC0 (csf_human)
pI: 8.44 Mw: 22449
%vol: 0.097402 %od: 0.150569
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BGA (csf_human)
pI: 5.00 Mw: 132770
%vol: 0.0885712 %od: 0.0458203
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BGA (csf_human)
pI: 5.00 Mw: 132770
%vol: 0.0885712 %od: 0.0458203
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9L (csf_human)
pI: 6.21 Mw: 27057
%vol: 0.182207 %od: 0.167323
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9L (csf_human)
pI: 6.21 Mw: 27057
%vol: 0.182207 %od: 0.167323
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BYG (csf_human)
pI: 6.51 Mw: 51921
%vol: 0.112727 %od: 0.174624
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BYG (csf_human)
pI: 6.51 Mw: 51921
%vol: 0.112727 %od: 0.174624
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BGB (csf_human)
pI: 5.12 Mw: 132770
%vol: 0.0522075 %od: 0.0129208
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BGB (csf_human)
pI: 5.12 Mw: 132770
%vol: 0.0522075 %od: 0.0129208
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CF9 (csf_human)
pI: 5.24 Mw: 13997
%vol: 0.274804 %od: 1.18143
================
*TTHY_HUMAN*
accession n°: P02766
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CF9 (csf_human)
pI: 5.24 Mw: 13997
%vol: 0.274804 %od: 1.18143
================
*TTHY_HUMAN*
accession n°: P02766
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BY8 (csf_human)
pI: 7.70 Mw: 51657
%vol: 0.126752 %od: 0.259759
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BY8 (csf_human)
pI: 7.70 Mw: 51657
%vol: 0.126752 %od: 0.259759
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAR (csf_human)
pI: 6.32 Mw: 24750
%vol: 0.0772722 %od: 0.0406583
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAR (csf_human)
pI: 6.32 Mw: 24750
%vol: 0.0772722 %od: 0.0406583
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C5D (csf_human)
pI: 4.85 Mw: 35883
%vol: 0.0614284 %od: 0.0287353
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C5D (csf_human)
pI: 4.85 Mw: 35883
%vol: 0.0614284 %od: 0.0287353
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BE5 (csf_human)
pI: 5.17 Mw: 151291
%vol: 0.0774021 %od: 0.0219208
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BE5 (csf_human)
pI: 5.17 Mw: 151291
%vol: 0.0774021 %od: 0.0219208
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C86 (csf_human)
pI: 6.54 Mw: 29949
%vol: 0.14883 %od: 0.173797
================
*CO4B_HUMAN*
accession n°: P0C0L5
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C86 (csf_human)
pI: 6.54 Mw: 29949
%vol: 0.14883 %od: 0.173797
================
*CO4B_HUMAN*
accession n°: P0C0L5
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CCN (csf_human)
pI: 7.68 Mw: 21464
%vol: 0.0574026 %od: 0.0280198
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CCN (csf_human)
pI: 7.68 Mw: 21464
%vol: 0.0574026 %od: 0.0280198
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BFT (csf_human)
pI: 5.25 Mw: 137521
%vol: 0.0432465 %od: 0.0199008
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BFT (csf_human)
pI: 5.25 Mw: 137521
%vol: 0.0432465 %od: 0.0199008
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBL (csf_human)
pI: 5.12 Mw: 23206
%vol: 0.213376 %od: 0.262011
================
*APOA1_HUMAN*
accession n°: P02647
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBL (csf_human)
pI: 5.12 Mw: 23206
%vol: 0.213376 %od: 0.262011
================
*APOA1_HUMAN*
accession n°: P02647
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C82 (csf_human)
pI: 5.21 Mw: 30097
%vol: 0.0167532 %od: 0.00878098
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C82 (csf_human)
pI: 5.21 Mw: 30097
%vol: 0.0167532 %od: 0.00878098
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BWW (csf_human)
pI: 5.15 Mw: 55193
%vol: 0.226622 %od: 0.290145
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BWW (csf_human)
pI: 5.15 Mw: 55193
%vol: 0.226622 %od: 0.290145
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BM0 (csf_human)
pI: 6.34 Mw: 84851
%vol: 0.123116 %od: 0.0407873
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BM0 (csf_human)
pI: 6.34 Mw: 84851
%vol: 0.123116 %od: 0.0407873
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CB2 (csf_human)
pI: 6.41 Mw: 24144
%vol: 0.145454 %od: 0.122627
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CB2 (csf_human)
pI: 6.41 Mw: 24144
%vol: 0.145454 %od: 0.122627
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C90 (csf_human)
pI: 6.04 Mw: 28361
%vol: 0.0425972 %od: 0.0245541
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C90 (csf_human)
pI: 6.04 Mw: 28361
%vol: 0.0425972 %od: 0.0245541
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BPP (csf_human)
pI: 5.55 Mw: 68937
%vol: 0.207531 %od: 0.272617
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BPP (csf_human)
pI: 5.55 Mw: 68937
%vol: 0.207531 %od: 0.272617
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BQ6 (csf_human)
pI: 5.98 Mw: 68436
%vol: 0.182207 %od: 0.0977493
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BQ6 (csf_human)
pI: 5.98 Mw: 68436
%vol: 0.182207 %od: 0.0977493
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BK1 (csf_human)
pI: 4.73 Mw: 97982
%vol: 0.067532 %od: 0.0571762
================
*C1S_HUMAN*
accession n°: P09871
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BK1 (csf_human)
pI: 4.73 Mw: 97982
%vol: 0.067532 %od: 0.0571762
================
*C1S_HUMAN*
accession n°: P09871
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BUV (csf_human)
pI: 4.96 Mw: 57051
%vol: 0.271817 %od: 0.942892
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BUV (csf_human)
pI: 4.96 Mw: 57051
%vol: 0.271817 %od: 0.942892
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CFD (csf_human)
pI: 5.04 Mw: 13997
%vol: 0.0792202 %od: 0.182838
================
*TTHY_HUMAN*
accession n°: P02766
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CFD (csf_human)
pI: 5.04 Mw: 13997
%vol: 0.0792202 %od: 0.182838
================
*TTHY_HUMAN*
accession n°: P02766
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBN (csf_human)
pI: 7.67 Mw: 22769
%vol: 0.158051 %od: 0.330302
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBN (csf_human)
pI: 7.67 Mw: 22769
%vol: 0.158051 %od: 0.330302
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CB3 (csf_human)
pI: 6.33 Mw: 23966
%vol: 0.105194 %od: 0.243877
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CB3 (csf_human)
pI: 6.33 Mw: 23966
%vol: 0.105194 %od: 0.243877
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BMW (csf_human)
pI: 5.02 Mw: 80926
%vol: 0.0676619 %od: 0.0547254
================
*A1BG_HUMAN*
accession n°: P04217
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BMW (csf_human)
pI: 5.02 Mw: 80926
%vol: 0.0676619 %od: 0.0547254
================
*A1BG_HUMAN*
accession n°: P04217
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9C (csf_human)
pI: 6.36 Mw: 27394
%vol: 0.0555843 %od: 0.0359003
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9C (csf_human)
pI: 6.36 Mw: 27394
%vol: 0.0555843 %od: 0.0359003
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BPM (csf_human)
pI: 5.50 Mw: 69189
%vol: 0.207142 %od: 0.179706
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BPM (csf_human)
pI: 5.50 Mw: 69189
%vol: 0.207142 %od: 0.179706
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAE (csf_human)
pI: 6.19 Mw: 25182
%vol: 0.0538958 %od: 0.0552389
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAE (csf_human)
pI: 6.19 Mw: 25182
%vol: 0.0538958 %od: 0.0552389
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BGK (csf_human)
pI: 5.21 Mw: 130832
%vol: 0.0674022 %od: 0.0265449
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BGK (csf_human)
pI: 5.21 Mw: 130832
%vol: 0.0674022 %od: 0.0265449
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CCJ (csf_human)
pI: 8.48 Mw: 21616
%vol: 0.055714 %od: 0.0360804
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CCJ (csf_human)
pI: 8.48 Mw: 21616
%vol: 0.055714 %od: 0.0360804
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CEB (csf_human)
pI: 5.40 Mw: 17109
%vol: 0.0472725 %od: 0.050257
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CEB (csf_human)
pI: 5.40 Mw: 17109
%vol: 0.0472725 %od: 0.050257
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BFU (csf_human)
pI: 5.29 Mw: 137521
%vol: 0.0475322 %od: 0.0219792
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BFU (csf_human)
pI: 5.29 Mw: 137521
%vol: 0.0475322 %od: 0.0219792
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BSF (csf_human)
pI: 4.65 Mw: 63492
%vol: 0.0494803 %od: 0.0235734
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BSF (csf_human)
pI: 4.65 Mw: 63492
%vol: 0.0494803 %od: 0.0235734
================
*AACT_HUMAN*
accession n°: P01011
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C88 (csf_human)
pI: 4.37 Mw: 29801
%vol: 0.0293505 %od: 0.0180998
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C88 (csf_human)
pI: 4.37 Mw: 29801
%vol: 0.0293505 %od: 0.0180998
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BYO (csf_human)
pI: 6.35 Mw: 51921
%vol: 0.101039 %od: 0.146276
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BYO (csf_human)
pI: 6.35 Mw: 51921
%vol: 0.101039 %od: 0.146276
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CH8 (csf_human)
pI: 5.71 Mw: 9270
%vol: 0.127012 %od: 0.163639
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CH8 (csf_human)
pI: 5.71 Mw: 9270
%vol: 0.127012 %od: 0.163639
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BN0 (csf_human)
pI: 5.07 Mw: 80338
%vol: 0.121168 %od: 0.109971
================
*A1BG_HUMAN*
accession n°: P04217
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BN0 (csf_human)
pI: 5.07 Mw: 80338
%vol: 0.121168 %od: 0.109971
================
*A1BG_HUMAN*
accession n°: P04217
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C91 (csf_human)
pI: 5.76 Mw: 28221
%vol: 0.0172726 %od: 0.00643484
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C91 (csf_human)
pI: 5.76 Mw: 28221
%vol: 0.0172726 %od: 0.00643484
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA1 (csf_human)
pI: 6.05 Mw: 25686
%vol: 0.022857 %od: 0.0209035
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA1 (csf_human)
pI: 6.05 Mw: 25686
%vol: 0.022857 %od: 0.0209035
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CB7 (csf_human)
pI: 6.48 Mw: 23847
%vol: 0.0641555 %od: 0.0508654
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CB7 (csf_human)
pI: 6.48 Mw: 23847
%vol: 0.0641555 %od: 0.0508654
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BX0 (csf_human)
pI: 7.17 Mw: 55193
%vol: 0.0984412 %od: 0.0922368
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BX0 (csf_human)
pI: 7.17 Mw: 55193
%vol: 0.0984412 %od: 0.0922368
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBO (csf_human)
pI: 6.46 Mw: 23264
%vol: 0.0376621 %od: 0.00951111
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBO (csf_human)
pI: 6.46 Mw: 23264
%vol: 0.0376621 %od: 0.00951111
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BUC (csf_human)
pI: 4.79 Mw: 58523
%vol: 0.159869 %od: 0.181342
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BUC (csf_human)
pI: 4.79 Mw: 58523
%vol: 0.159869 %od: 0.181342
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BYY (csf_human)
pI: 5.53 Mw: 51526
%vol: 0.162986 %od: 0.250119
================
*FIBG_HUMAN*
accession n°: P02679
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BYY (csf_human)
pI: 5.53 Mw: 51526
%vol: 0.162986 %od: 0.250119
================
*FIBG_HUMAN*
accession n°: P02679
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BX3 (csf_human)
pI: 7.04 Mw: 54913
%vol: 0.105714 %od: 0.126942
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BX3 (csf_human)
pI: 7.04 Mw: 54913
%vol: 0.105714 %od: 0.126942
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BIV (csf_human)
pI: 6.59 Mw: 107543
%vol: 0.0444154 %od: 0.0177908
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BIV (csf_human)
pI: 6.59 Mw: 107543
%vol: 0.0444154 %od: 0.0177908
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CC4 (csf_human)
pI: 7.03 Mw: 22502
%vol: 0.0931167 %od: 0.101032
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CC4 (csf_human)
pI: 7.03 Mw: 22502
%vol: 0.0931167 %od: 0.101032
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8X (csf_human)
pI: 5.33 Mw: 28502
%vol: 0.0274025 %od: 0.0176496
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8X (csf_human)
pI: 5.33 Mw: 28502
%vol: 0.0274025 %od: 0.0176496
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C94 (csf_human)
pI: 4.38 Mw: 27943
%vol: 0.0237661 %od: 0.0123732
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C94 (csf_human)
pI: 4.38 Mw: 27943
%vol: 0.0237661 %od: 0.0123732
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C77 (csf_human)
pI: 5.60 Mw: 32019
%vol: 0.108181 %od: 0.0749133
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C77 (csf_human)
pI: 5.60 Mw: 32019
%vol: 0.108181 %od: 0.0749133
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C5Q (csf_human)
pI: 4.95 Mw: 35005
%vol: 0.0819475 %od: 0.0588092
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C5Q (csf_human)
pI: 4.95 Mw: 35005
%vol: 0.0819475 %od: 0.0588092
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C0Z (csf_human)
pI: 4.57 Mw: 47312
%vol: 0.0416881 %od: 0.0194505
================
*A2GL_HUMAN*
accession n°: P02750
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C0Z (csf_human)
pI: 4.57 Mw: 47312
%vol: 0.0416881 %od: 0.0194505
================
*A2GL_HUMAN*
accession n°: P02750
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BU5 (csf_human)
pI: 4.47 Mw: 59576
%vol: 0.0774021 %od: 0.0511453
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BU5 (csf_human)
pI: 4.47 Mw: 59576
%vol: 0.0774021 %od: 0.0511453
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA5 (csf_human)
pI: 6.41 Mw: 25686
%vol: 0.290648 %od: 0.465256
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA5 (csf_human)
pI: 6.41 Mw: 25686
%vol: 0.290648 %od: 0.465256
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BEV (csf_human)
pI: 4.91 Mw: 145333
%vol: 0.0432465 %od: 0.0241696
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BEV (csf_human)
pI: 4.91 Mw: 145333
%vol: 0.0432465 %od: 0.0241696
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BK7 (csf_human)
pI: 4.77 Mw: 96552
%vol: 0.0733761 %od: 0.0376818
================
*C1S_HUMAN*
accession n°: P09871
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BK7 (csf_human)
pI: 4.77 Mw: 96552
%vol: 0.0733761 %od: 0.0376818
================
*C1S_HUMAN*
accession n°: P09871
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BPS (csf_human)
pI: 5.52 Mw: 68937
%vol: 0.202726 %od: 0.1653
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BPS (csf_human)
pI: 5.52 Mw: 68937
%vol: 0.202726 %od: 0.1653
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BIR (csf_human)
pI: 6.78 Mw: 107543
%vol: 0.0515582 %od: 0.0500501
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BIR (csf_human)
pI: 6.78 Mw: 107543
%vol: 0.0515582 %od: 0.0500501
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BW0 (csf_human)
pI: 5.24 Mw: 56617
%vol: 0.218311 %od: 0.199466
================
*VTDB_HUMAN*
accession n°: P02774
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BW0 (csf_human)
pI: 5.24 Mw: 56617
%vol: 0.218311 %od: 0.199466
================
*VTDB_HUMAN*
accession n°: P02774
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CC1 (csf_human)
pI: 7.28 Mw: 22502
%vol: 0.221038 %od: 0.288142
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CC1 (csf_human)
pI: 7.28 Mw: 22502
%vol: 0.221038 %od: 0.288142
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA2 (csf_human)
pI: 6.10 Mw: 25750
%vol: 0.0435063 %od: 0.0399914
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA2 (csf_human)
pI: 6.10 Mw: 25750
%vol: 0.0435063 %od: 0.0399914
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BGC (csf_human)
pI: 5.29 Mw: 132770
%vol: 0.0441556 %od: 0.0112877
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BGC (csf_human)
pI: 5.29 Mw: 132770
%vol: 0.0441556 %od: 0.0112877
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BIH (csf_human)
pI: 6.99 Mw: 110752
%vol: 0.0409089 %od: 0.0184673
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BIH (csf_human)
pI: 6.99 Mw: 110752
%vol: 0.0409089 %od: 0.0184673
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBH (csf_human)
pI: 7.07 Mw: 23496
%vol: 0.196492 %od: 0.209858
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBH (csf_human)
pI: 7.07 Mw: 23496
%vol: 0.196492 %od: 0.209858
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BYJ (csf_human)
pI: 6.24 Mw: 52319
%vol: 0.127792 %od: 0.112698
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BYJ (csf_human)
pI: 6.24 Mw: 52319
%vol: 0.127792 %od: 0.112698
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9N (csf_human)
pI: 5.81 Mw: 26924
%vol: 0.0518179 %od: 0.0143105
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9N (csf_human)
pI: 5.81 Mw: 26924
%vol: 0.0518179 %od: 0.0143105
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BLL (csf_human)
pI: 4.94 Mw: 86412
%vol: 0.0683112 %od: 0.0660764
================
*THRB_HUMAN*
accession n°: P00734
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BLL (csf_human)
pI: 4.94 Mw: 86412
%vol: 0.0683112 %od: 0.0660764
================
*THRB_HUMAN*
accession n°: P00734
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BYB (csf_human)
pI: 8.27 Mw: 52186
%vol: 0.0893503 %od: 0.151618
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BYB (csf_human)
pI: 8.27 Mw: 52186
%vol: 0.0893503 %od: 0.151618
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C4I (csf_human)
pI: 5.04 Mw: 36691
%vol: 0.13909 %od: 0.369607
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C4I (csf_human)
pI: 5.04 Mw: 36691
%vol: 0.13909 %od: 0.369607
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CH4 (csf_human)
pI: 5.42 Mw: 9374
%vol: 0.111948 %od: 0.159752
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CH4 (csf_human)
pI: 5.42 Mw: 9374
%vol: 0.111948 %od: 0.159752
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BF9 (csf_human)
pI: 5.03 Mw: 143159
%vol: 0.0415582 %od: 0.0216702
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BF9 (csf_human)
pI: 5.03 Mw: 143159
%vol: 0.0415582 %od: 0.0216702
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C0A (csf_human)
pI: 4.51 Mw: 48719
%vol: 0.0579216 %od: 0.0413592
================
*A2GL_HUMAN*
accession n°: P02750
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C0A (csf_human)
pI: 4.51 Mw: 48719
%vol: 0.0579216 %od: 0.0413592
================
*A2GL_HUMAN*
accession n°: P02750
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BFG (csf_human)
pI: 5.08 Mw: 141728
%vol: 0.0442855 %od: 0.0222689
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BFG (csf_human)
pI: 5.08 Mw: 141728
%vol: 0.0442855 %od: 0.0222689
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BFS (csf_human)
pI: 5.21 Mw: 137521
%vol: 0.0454543 %od: 0.0217943
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BFS (csf_human)
pI: 5.21 Mw: 137521
%vol: 0.0454543 %od: 0.0217943
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9R (csf_human)
pI: 6.68 Mw: 26527
%vol: 0.175973 %od: 0.21683
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9R (csf_human)
pI: 6.68 Mw: 26527
%vol: 0.175973 %od: 0.21683
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C5G (csf_human)
pI: 4.93 Mw: 35705
%vol: 0.104805 %od: 0.0820126
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C5G (csf_human)
pI: 4.93 Mw: 35705
%vol: 0.104805 %od: 0.0820126
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BPE (csf_human)
pI: 5.77 Mw: 68686
%vol: 0.206363 %od: 0.39418
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BPE (csf_human)
pI: 5.77 Mw: 68686
%vol: 0.206363 %od: 0.39418
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CB6 (csf_human)
pI: 6.24 Mw: 23966
%vol: 0.0223375 %od: 0.0088759
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CB6 (csf_human)
pI: 6.24 Mw: 23966
%vol: 0.0223375 %od: 0.0088759
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAJ (csf_human)
pI: 6.42 Mw: 24934
%vol: 0.252466 %od: 0.226957
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAJ (csf_human)
pI: 6.42 Mw: 24934
%vol: 0.252466 %od: 0.226957
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C7N (csf_human)
pI: 4.22 Mw: 30928
%vol: 0.01987 %od: 0.0143519
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C7N (csf_human)
pI: 4.22 Mw: 30928
%vol: 0.01987 %od: 0.0143519
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BGI (csf_human)
pI: 5.17 Mw: 131475
%vol: 0.0662333 %od: 0.0235734
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BGI (csf_human)
pI: 5.17 Mw: 131475
%vol: 0.0662333 %od: 0.0235734
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BMN (csf_human)
pI: 6.17 Mw: 82114
%vol: 0.126233 %od: 0.168859
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BMN (csf_human)
pI: 6.17 Mw: 82114
%vol: 0.126233 %od: 0.168859
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BEI (csf_human)
pI: 4.83 Mw: 146064
%vol: 0.0379219 %od: 0.024138
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BEI (csf_human)
pI: 4.83 Mw: 146064
%vol: 0.0379219 %od: 0.024138
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA0 (csf_human)
pI: 7.05 Mw: 26006
%vol: 0.0370128 %od: 0.0203462
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA0 (csf_human)
pI: 7.05 Mw: 26006
%vol: 0.0370128 %od: 0.0203462
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BMT (csf_human)
pI: 6.25 Mw: 81221
%vol: 0.191298 %od: 0.10194
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BMT (csf_human)
pI: 6.25 Mw: 81221
%vol: 0.191298 %od: 0.10194
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BGL (csf_human)
pI: 5.25 Mw: 130193
%vol: 0.0449348 %od: 0.0225171
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BGL (csf_human)
pI: 5.25 Mw: 130193
%vol: 0.0449348 %od: 0.0225171
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C2J (csf_human)
pI: 5.20 Mw: 42428
%vol: 0.19922 %od: 0.279655
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C2J (csf_human)
pI: 5.20 Mw: 42428
%vol: 0.19922 %od: 0.279655
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C5E (csf_human)
pI: 5.28 Mw: 35353
%vol: 0.134804 %od: 0.304316
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C5E (csf_human)
pI: 5.28 Mw: 35353
%vol: 0.134804 %od: 0.304316
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8M (csf_human)
pI: 4.23 Mw: 29144
%vol: 0.0157142 %od: 0.00539563
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8M (csf_human)
pI: 4.23 Mw: 29144
%vol: 0.0157142 %od: 0.00539563
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BY9 (csf_human)
pI: 7.99 Mw: 51921
%vol: 0.123895 %od: 0.249056
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BY9 (csf_human)
pI: 7.99 Mw: 51921
%vol: 0.123895 %od: 0.249056
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C5Z (csf_human)
pI: 5.04 Mw: 34318
%vol: 0.0741553 %od: 0.0251212
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C5Z (csf_human)
pI: 5.04 Mw: 34318
%vol: 0.0741553 %od: 0.0251212
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C3B (csf_human)
pI: 5.20 Mw: 40915
%vol: 0.200259 %od: 0.180417
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C3B (csf_human)
pI: 5.20 Mw: 40915
%vol: 0.200259 %od: 0.180417
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BNJ (csf_human)
pI: 6.80 Mw: 76064
%vol: 0.222726 %od: 0.372802
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BNJ (csf_human)
pI: 6.80 Mw: 76064
%vol: 0.222726 %od: 0.372802
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BGH (csf_human)
pI: 5.06 Mw: 130832
%vol: 0.0796101 %od: 0.0420236
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BGH (csf_human)
pI: 5.06 Mw: 130832
%vol: 0.0796101 %od: 0.0420236
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BQB (csf_human)
pI: 5.45 Mw: 68686
%vol: 0.205194 %od: 0.0825286
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BQB (csf_human)
pI: 5.45 Mw: 68686
%vol: 0.205194 %od: 0.0825286
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9Z (csf_human)
pI: 5.76 Mw: 26006
%vol: 0.0248051 %od: 0.0121736
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9Z (csf_human)
pI: 5.76 Mw: 26006
%vol: 0.0248051 %od: 0.0121736
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BU7 (csf_human)
pI: 4.42 Mw: 59576
%vol: 0.0514283 %od: 0.0162647
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BU7 (csf_human)
pI: 4.42 Mw: 59576
%vol: 0.0514283 %od: 0.0162647
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BVO (csf_human)
pI: 5.12 Mw: 57051
%vol: 0.205843 %od: 0.162592
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BVO (csf_human)
pI: 5.12 Mw: 57051
%vol: 0.205843 %od: 0.162592
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BLJ (csf_human)
pI: 6.09 Mw: 87680
%vol: 0.0266232 %od: 0.0182385
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BLJ (csf_human)
pI: 6.09 Mw: 87680
%vol: 0.0266232 %od: 0.0182385
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8T (csf_human)
pI: 4.55 Mw: 28714
%vol: 0.0261038 %od: 0.0128867
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8T (csf_human)
pI: 4.55 Mw: 28714
%vol: 0.0261038 %od: 0.0128867
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BXY (csf_human)
pI: 6.31 Mw: 53260
%vol: 0.136623 %od: 0.101583
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BXY (csf_human)
pI: 6.31 Mw: 53260
%vol: 0.136623 %od: 0.101583
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BQF (csf_human)
pI: 5.67 Mw: 65796
%vol: 0.211168 %od: 0.802985
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BQF (csf_human)
pI: 5.67 Mw: 65796
%vol: 0.211168 %od: 0.802985
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C85 (csf_human)
pI: 4.21 Mw: 30097
%vol: 0.0183116 %od: 0.00362629
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C85 (csf_human)
pI: 4.21 Mw: 30097
%vol: 0.0183116 %od: 0.00362629
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BQ0 (csf_human)
pI: 5.96 Mw: 68686
%vol: 0.190648 %od: 0.187937
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BQ0 (csf_human)
pI: 5.96 Mw: 68686
%vol: 0.190648 %od: 0.187937
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C2O (csf_human)
pI: 4.93 Mw: 42557
%vol: 0.11987 %od: 0.0618855
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C2O (csf_human)
pI: 4.93 Mw: 42557
%vol: 0.11987 %od: 0.0618855
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BN7 (csf_human)
pI: 5.34 Mw: 77746
%vol: 0.0819475 %od: 0.160175
================
*HEMO_HUMAN*
accession n°: P02790
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BN7 (csf_human)
pI: 5.34 Mw: 77746
%vol: 0.0819475 %od: 0.160175
================
*HEMO_HUMAN*
accession n°: P02790
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9J (csf_human)
pI: 6.05 Mw: 27124
%vol: 0.0625973 %od: 0.0379812
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9J (csf_human)
pI: 6.05 Mw: 27124
%vol: 0.0625973 %od: 0.0379812
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BZL (csf_human)
pI: 4.45 Mw: 50103
%vol: 0.0405193 %od: 0.0235052
================
*A2GL_HUMAN*
accession n°: P02750
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BZL (csf_human)
pI: 4.45 Mw: 50103
%vol: 0.0405193 %od: 0.0235052
================
*A2GL_HUMAN*
accession n°: P02750
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9O (csf_human)
pI: 6.27 Mw: 26857
%vol: 0.0445452 %od: 0.023622
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9O (csf_human)
pI: 6.27 Mw: 26857
%vol: 0.0445452 %od: 0.023622
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BGF (csf_human)
pI: 5.14 Mw: 132121
%vol: 0.0658441 %od: 0.0214073
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BGF (csf_human)
pI: 5.14 Mw: 132121
%vol: 0.0658441 %od: 0.0214073
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BZ3 (csf_human)
pI: 4.40 Mw: 51395
%vol: 0.0285713 %od: 0.018645
================
*A2GL_HUMAN*
accession n°: P02750
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BZ3 (csf_human)
pI: 4.40 Mw: 51395
%vol: 0.0285713 %od: 0.018645
================
*A2GL_HUMAN*
accession n°: P02750
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BU8 (csf_human)
pI: 4.90 Mw: 57782
%vol: 0.255193 %od: 0.675746
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BU8 (csf_human)
pI: 4.90 Mw: 57782
%vol: 0.255193 %od: 0.675746
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BVZ (csf_human)
pI: 5.17 Mw: 56617
%vol: 0.230129 %od: 0.196888
================
*VTDB_HUMAN*
accession n°: P02774
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BVZ (csf_human)
pI: 5.17 Mw: 56617
%vol: 0.230129 %od: 0.196888
================
*VTDB_HUMAN*
accession n°: P02774
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BF1 (csf_human)
pI: 4.95 Mw: 143880
%vol: 0.0431167 %od: 0.0299571
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BF1 (csf_human)
pI: 4.95 Mw: 143880
%vol: 0.0431167 %od: 0.0299571
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BQ8 (csf_human)
pI: 6.06 Mw: 68686
%vol: 0.126233 %od: 0.0859942
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BQ8 (csf_human)
pI: 6.06 Mw: 68686
%vol: 0.126233 %od: 0.0859942
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C1O (csf_human)
pI: 5.09 Mw: 45212
%vol: 0.137921 %od: 0.0652392
================
*APOA4_HUMAN*
accession n°: P06727
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C1O (csf_human)
pI: 5.09 Mw: 45212
%vol: 0.137921 %od: 0.0652392
================
*APOA4_HUMAN*
accession n°: P06727
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BLH (csf_human)
pI: 4.82 Mw: 87361
%vol: 0.0488309 %od: 0.0582811
================
*THRB_HUMAN*
accession n°: P00734
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BLH (csf_human)
pI: 4.82 Mw: 87361
%vol: 0.0488309 %od: 0.0582811
================
*THRB_HUMAN*
accession n°: P00734
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BO8 (csf_human)
pI: 5.58 Mw: 73076
%vol: 0.215973 %od: 0.338423
================
*HEMO_HUMAN*
accession n°: P02790
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BO8 (csf_human)
pI: 5.58 Mw: 73076
%vol: 0.215973 %od: 0.338423
================
*HEMO_HUMAN*
accession n°: P02790
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAX (csf_human)
pI: 6.18 Mw: 24324
%vol: 0.0405193 %od: 0.0420528
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAX (csf_human)
pI: 6.18 Mw: 24324
%vol: 0.0405193 %od: 0.0420528
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C79 (csf_human)
pI: 5.47 Mw: 31940
%vol: 0.172207 %od: 0.120424
================
*APOE_HUMAN*
accession n°: P02649
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C79 (csf_human)
pI: 5.47 Mw: 31940
%vol: 0.172207 %od: 0.120424
================
*APOE_HUMAN*
accession n°: P02649
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BJG (csf_human)
pI: 5.99 Mw: 103408
%vol: 0.145714 %od: 0.12445
================
*CO3_HUMAN*
accession n°: P01024
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BJG (csf_human)
pI: 5.99 Mw: 103408
%vol: 0.145714 %od: 0.12445
================
*CO3_HUMAN*
accession n°: P01024
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BEJ (csf_human)
pI: 5.32 Mw: 146800
%vol: 0.0685712 %od: 0.0403273
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BEJ (csf_human)
pI: 5.32 Mw: 146800
%vol: 0.0685712 %od: 0.0403273
================
*CERU_HUMAN*
accession n°: P00450
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9Q (csf_human)
pI: 6.40 Mw: 26724
%vol: 0.096233 %od: 0.0547887
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9Q (csf_human)
pI: 6.40 Mw: 26724
%vol: 0.096233 %od: 0.0547887
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BYA (csf_human)
pI: 8.10 Mw: 52990
%vol: 0.103246 %od: 0.0293754
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BYA (csf_human)
pI: 8.10 Mw: 52990
%vol: 0.103246 %od: 0.0293754
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BXF (csf_human)
pI: 6.57 Mw: 54080
%vol: 0.115064 %od: 0.142737
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BXF (csf_human)
pI: 6.57 Mw: 54080
%vol: 0.115064 %od: 0.142737
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BMU (csf_human)
pI: 6.29 Mw: 80631
%vol: 0.237012 %od: 0.661436
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BMU (csf_human)
pI: 6.29 Mw: 80631
%vol: 0.237012 %od: 0.661436
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BY6 (csf_human)
pI: 7.18 Mw: 51789
%vol: 0.185194 %od: 0.605418
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BY6 (csf_human)
pI: 7.18 Mw: 51789
%vol: 0.185194 %od: 0.605418
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BTU (csf_human)
pI: 4.83 Mw: 59122
%vol: 0.211298 %od: 0.422831
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BTU (csf_human)
pI: 4.83 Mw: 59122
%vol: 0.211298 %od: 0.422831
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BUU (csf_human)
pI: 4.55 Mw: 58077
%vol: 0.0870124 %od: 0.0660813
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BUU (csf_human)
pI: 4.55 Mw: 58077
%vol: 0.0870124 %od: 0.0660813
================
*FETUA_HUMAN*
accession n°: P02765
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BX4 (csf_human)
pI: 7.33 Mw: 55475
%vol: 0.0662333 %od: 0.0426491
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BX4 (csf_human)
pI: 7.33 Mw: 55475
%vol: 0.0662333 %od: 0.0426491
================
*IGHG_HUMAN*
accession n°: P99006
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8C (csf_human)
pI: 5.07 Mw: 29801
%vol: 0.0764931 %od: 0.0537348
================
*AMBP_HUMAN*
accession n°: P02760
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8C (csf_human)
pI: 5.07 Mw: 29801
%vol: 0.0764931 %od: 0.0537348
================
*AMBP_HUMAN*
accession n°: P02760
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8K (csf_human)
pI: 5.95 Mw: 29072
%vol: 0.0335063 %od: 0.0421404
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8K (csf_human)
pI: 5.95 Mw: 29072
%vol: 0.0335063 %od: 0.0421404
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C5R (csf_human)
pI: 5.45 Mw: 34403
%vol: 0.122987 %od: 0.352388
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C5R (csf_human)
pI: 5.45 Mw: 34403
%vol: 0.122987 %od: 0.352388
================
*CLUS_HUMAN*
accession n°: P10909
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8Y (csf_human)
pI: 5.48 Mw: 28361
%vol: 0.0175324 %od: 0.00813604
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8Y (csf_human)
pI: 5.48 Mw: 28361
%vol: 0.0175324 %od: 0.00813604
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CFA (csf_human)
pI: 5.49 Mw: 13800
%vol: 0.312206 %od: 2.8086
================
*TTHY_HUMAN*
accession n°: P02766
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CFA (csf_human)
pI: 5.49 Mw: 13800
%vol: 0.312206 %od: 2.8086
================
*TTHY_HUMAN*
accession n°: P02766
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BID (csf_human)
pI: 6.68 Mw: 112945
%vol: 0.0449348 %od: 0.0225657
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BID (csf_human)
pI: 6.68 Mw: 112945
%vol: 0.0449348 %od: 0.0225657
================
*PLMN_HUMAN*
accession n°: P00747
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9V (csf_human)
pI: 4.79 Mw: 26071
%vol: 0.0575323 %od: 0.119388
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9V (csf_human)
pI: 4.79 Mw: 26071
%vol: 0.0575323 %od: 0.119388
================
*APOD_HUMAN*
accession n°: P05090
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAN (csf_human)
pI: 7.40 Mw: 23379
%vol: 0.279219 %od: 2.42095
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAN (csf_human)
pI: 7.40 Mw: 23379
%vol: 0.279219 %od: 2.42095
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAT (csf_human)
pI: 5.90 Mw: 23906
%vol: 0.0479218 %od: 0.0608487
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAT (csf_human)
pI: 5.90 Mw: 23906
%vol: 0.0479218 %od: 0.0608487
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BQ4 (csf_human)
pI: 5.47 Mw: 68686
%vol: 0.205843 %od: 0.151576
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BQ4 (csf_human)
pI: 5.47 Mw: 68686
%vol: 0.205843 %od: 0.151576
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBJ (csf_human)
pI: 5.47 Mw: 23322
%vol: 0.0225973 %od: 0.0132932
================
*APOA1_HUMAN*
accession n°: P02647
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBJ (csf_human)
pI: 5.47 Mw: 23322
%vol: 0.0225973 %od: 0.0132932
================
*APOA1_HUMAN*
accession n°: P02647
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAP (csf_human)
pI: 6.11 Mw: 24811
%vol: 0.0363634 %od: 0.0235587
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAP (csf_human)
pI: 6.11 Mw: 24811
%vol: 0.0363634 %od: 0.0235587
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000BN9 (csf_human)
pI: 5.18 Mw: 79175
%vol: 0.14935 %od: 0.106324
================
*A1BG_HUMAN*
accession n°: P04217
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000BN9 (csf_human)
pI: 5.18 Mw: 79175
%vol: 0.14935 %od: 0.106324
================
*A1BG_HUMAN*
accession n°: P04217
Identification Methods:
* MAPPING: {Gm}
SWISS-2DPAGE Viewer
|
Back to the search engine |
-Get more information by dragging your mouse pointer over any highlighted spot -Click on a highlighted spot to access all its associated protein entries
Back to the
search engine